Reitz, M <br/><br/>
Coagulation factors and proteinase inhibitors in the plasma of children with acute lymphoblastic leukoses. Behaviour before and during treatment according to Protocol I of the Cooperative Leukaemia Study COALL-80.  [electronic resource] 

 -  Klinische Wochenschrift  Dec 1984 
 - 1165-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0023-2173 
<br/><br/><label>Standard No.: </label>10.1007/BF01712183  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Antithrombin III--metabolism<br/>Blood Coagulation Factors--metabolism<br/>Child<br/>Child, Preschool<br/>Complement C1 Inactivator Proteins--blood<br/>Factor XIII--metabolism<br/>Female<br/>Fibrinogen--metabolism<br/>Fibronectins--blood<br/>Humans<br/>Leukemia, Lymphoid--drug therapy<br/>Male<br/>Protease Inhibitors--blood<br/>Prothrombin--metabolism<br/>alpha 1-Antitrypsin--metabolism<br/>alpha-Macroglobulins--metabolism